Norges Bank purchased a new stake in Humana Inc. (NYSE:HUM – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 1,782,815 shares of the insurance provider’s stock, valued at approximately $456,632,000. Norges Bank owned about 1.48% of Humana at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Montag A & Associates Inc. lifted its stake in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC lifted its stake in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in Humana in the fourth quarter valued at $27,000. Rosenberg Matthew Hamilton lifted its stake in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the last quarter. Finally, Larson Financial Group LLC lifted its stake in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have commented on HUM shares. Truist Financial increased their price target on shares of Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday. TD Cowen increased their price target on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research note on Friday, May 1st. Zacks Research raised shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Raymond James Financial reissued an “outperform” rating and issued a $260.00 price objective on shares of Humana in a research report on Friday, May 1st. Finally, Seaport Research Partners lowered shares of Humana to a “neutral” rating in a research report on Wednesday, May 20th. Nine investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $272.65.
Humana Price Performance
Shares of HUM opened at $328.19 on Tuesday. The firm has a market capitalization of $39.40 billion, a PE ratio of 35.10, a PEG ratio of 2.21 and a beta of 0.68. The company’s 50-day moving average is $235.19 and its 200-day moving average is $229.58. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $333.31. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same period in the prior year, the firm earned $11.58 earnings per share. The company’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts forecast that Humana Inc. will post 9.01 EPS for the current year.
Humana Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio (DPR) is currently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
